Navigation Links
Exclusive Conference on Managing Your Online Brand: Shaping the Noise from the Blogosphere
Date:12/11/2008

CHAPEL HILL, N.C., Dec. 11 /PRNewswire/ -- Health-focused social networks, blogs, wikis and community sites are pharmaceutical and biotech companies' biggest challenges but can be their biggest opportunities. A marketing executive from a large biopharmaceutical company will discuss increasing importance of reputation monitoring and management in "The Crowd's Noise Level is Increasing: Understanding User Generated Content and Enhancing its Impact on Your Reputation" at the 11th Annual Customer Experience Conference.

Download the customer experience conference brochure at http://www3.best-in-class.com/gr185.htm to see more details about this presentation and others on slate for "Integrated Customer Strategies: Enabling Companies to Survive & Thrive through the Downturn" (http://www3.best-in-class.com/gr182.htm) in Las Vegas, Nev., Feb. 2-4, 2009.

Thought leaders from Abbott, Eli Lilly, Genentech, Roche, UCB Pharma, Cardinal Health, Pfizer, Toyota, Boeing, Johnson & Johnson and many others have attended this annual event in the past.

This year, customer service, marketing, sales and quality leaders from leading companies will gather to network with and to learn from successful executives and profitable companies that listen to, engage and align with external and internal customers to strengthen client relationships through an integrated customer strategy.

Register today for this working conference at http://www3.best-in-class.com/gr180.htm. Early bird registration special ($250 discount) ends December 19. Save more than $100 on hotel expenses when you register before January 2, 2009.

For more conference information, contact Shelley Alfred-Watkins at 919.767.9254 or salfred-watkins@best-in-class.com.

Sponsored by Best Practices, LLC's GLOBAL BENCHMARKING COUNCIL, the 11th Annual Customer Experience Conference represents one of the networking opportunities at the core of the GLOBAL BENCHMARKING COUNCIL's (www.globalbenchmarking.com) mission to promote primary research, knowledge exchange, and operational excellence in three broad areas of business operations:

    -- Customer Experience
    -- Human Capital Management
    -- Quality, Productivity and Process Excellence

Best Practices, LLC's GLOBAL BENCHMARKING COUNCIL is an innovative research, benchmarking and networking service for business executives in pharmaceutical and life sciences, consumer and industrial products manufacturing, financial services and other industries to promote top-line revenue growth, cost reduction and innovative problem-solving.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Minimally Invasive Surgery: Olympus Further Enhances Credentials by Entering Into Exclusive Sales and Distribution Partnership With Market and Technology Leader Advanced Surgical Concepts
2. FCSO Selects Burgess as Exclusive Pricing Solution for New Medicare Contract
3. Transgenomic Signs Letter of Intent for an Agreement to Exclusive License With Option to Acquire Power3 Medical Products Neurodegenerative Diagnostics
4. VisualSonics and Seno Medical Instruments Sign Exclusive Opto-Accoustic Licensing Agreement for Preclinical Research
5. Cryo-Cell Renews Upromise Industry-Exclusive Agreement
6. GlaxoSmithKline and AFFiRiS Sign an Exclusive Licence and Option Agreement for Therapeutic Alzheimers Disease Candidate Vaccines
7. Huifeng Bio-Pharmaceutical (HFGB) Signs Exclusive Management Operating Agreement with Xian Qinba Xintong Medical Ltd.; HFGB to Retain Up to 70% of Qinbas Total Profit
8. The Modern DeBakey VAD™ To Be Introduced For the First Time in the U.S. : HeartAssist 5™ Pediatric VAD Features Industry Exclusive Direct Blood Flow Measurement System
9. Sigma-Aldrich Signs Exclusive Agreement With IsoSciences, LLC, to Distribute Isotopically Labeled Bioactive Compounds
10. CEL-SCI Announces Exclusive Licensing Agreement with Teva for Cancer Drug Multikine
11. ArunA Biomedical Announces Exclusive Worldwide Technology Licensing Agreement to Commercialize Human Embryonic Stem Cell Derived Mesenchymal Cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... -- Market Research Future published a half-cooked research report on Global Cancer ... a CAGR of 12% during the period 2016 to 2022. ... ... division without any control. These abnormal cells have the ability to ... can spread to other parts of the body through the blood ...
(Date:1/17/2017)... DIEGO , Jan. 17, 2017  An ... School of Medicine and St. Boniface Hospital Albrechtsen ... for peripheral neuropathy, an unmet health need affecting ... the Journal of Clinical Investigation, their results identify ... that prevent and reverse neuronal injury in animal ...
(Date:1/17/2017)... Noom Inc. , the leader ... offer fully Spanish behavior change programs that address ... prevention and healthy weight management programs  have ... interventions among Hispanic Americans who are at increased ... database, program-specific curriculum content and program features are ...
(Date:1/17/2017)... ... January 17, 2017 , ... ... of the North American Spine Society (NASS)1 demonstrate high fusion rates at ... cases, when PEEK-OPTIMA™ HA Enhanced is used for interbody-fusion devices. The implantable ...
Breaking Biology Technology:
(Date:12/7/2016)... -- According to a new market research report "Emotion Detection and ... Recognition), Service, Application Area, End User, And Region - Global Forecast to 2021", ... Billion in 2016 to USD 36.07 Billion by 2021, at a Compound Annual ... ... MarketsandMarkets Logo ...
(Date:12/7/2016)...   Avanade is helping Williams Martini Racing, ... history, exploit biometric data in order to critically analyse ... competitive edge against their rivals after their impressive, record-breaking ... has worked with Williams during the 2016 season to ... rate, breathing rate, temperature and peak acceleration) for key ...
(Date:12/6/2016)...  Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) (the ... €500.0 million principal amount of its 1.414% senior unsecured notes ... senior unsecured notes due 2026. The closing ... subject to the satisfaction of customary closing conditions.  The notes ... The Company intends to use the net proceeds ...
Breaking Biology News(10 mins):